Alexandria Real Estate Equities Inc
NYSE:ARE

Watchlist Manager
Alexandria Real Estate Equities Inc Logo
Alexandria Real Estate Equities Inc
NYSE:ARE
Watchlist
Price: 98.91 USD -0.26% Market Closed
Market Cap: 17.3B USD
Have any thoughts about
Alexandria Real Estate Equities Inc?
Write Note

Alexandria Real Estate Equities Inc
Stock-Based Compensation

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alexandria Real Estate Equities Inc
Stock-Based Compensation Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Stock-Based Compensation CAGR 3Y CAGR 5Y CAGR 10Y
Alexandria Real Estate Equities Inc
NYSE:ARE
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Boston Properties Inc
NYSE:BXP
Stock-Based Compensation
$45.1m
CAGR 3-Years
-4%
CAGR 5-Years
2%
CAGR 10-Years
5%
Kilroy Realty Corp
NYSE:KRC
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vornado Realty Trust
NYSE:VNO
Stock-Based Compensation
$32.8m
CAGR 3-Years
-8%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
Cousins Properties Inc
NYSE:CUZ
Stock-Based Compensation
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
COPT Defense Properties
NYSE:CDP
Stock-Based Compensation
$8.5m
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
3%
No Stocks Found

Alexandria Real Estate Equities Inc
Glance View

Market Cap
17B USD
Industry
Real Estate
Economic Moat
None

In the bustling hub of urban life sciences and technology campuses, Alexandria Real Estate Equities Inc. has carved a niche that integrates real estate acumen with a deep understanding of the life sciences industry. Born in 1994, it emerged as a visionary undertaking, keenly focused on serving the unique needs of life sciences enterprises by providing strategically located and highly sophisticated laboratory and office spaces. Headquartered in Pasadena, California, Alexandria has built a reputation not just as a landlord, but as a partner to a broad spectrum of innovative tenants ranging from biotech startups to global pharmaceutical giants. The company’s properties are primarily located in top innovation clusters like Greater Boston, San Francisco Bay Area, New York City, and San Diego, ensuring close proximity to leading research institutions and talent pools. Alexandria’s business model thrives on a keen strategy of acquiring, developing, and operating properties in these sought-after corridors, where science and technology entrepreneurship flourishes. The company generates revenue through leasing its carefully curated real estate portfolio, with rental income forming the backbone of its financial success. Each property is designed or upgraded to meet the demanding requirements of its tenants, often including state-of-the-art laboratory facilities and amenities that foster collaboration and innovation. This not only enables Alexandria to command premium lease rates but also helps maintain high occupancy levels. The uniqueness of its properties and strategic presence in dynamic markets provide Alexandria with a strong competitive edge, underpinning its growth and establishing its stature in the specialized domain of life sciences real estate investment trusts (REITs).

ARE Intrinsic Value
116.17 USD
Undervaluation 15%
Intrinsic Value
Price

See Also

Back to Top